Blogs

Heating Oil – Gasoline Spread 2017 - 2018 (Preview)

By Lawrence G. McMillan

This has been a successful seasonal trade in many years, and the last two years were the second and third best years in our history.  We have used this in 23 of the past 24 years – skipping only 1995, for reasons which I no longer recall.

In this trade, we buy RBOB Gasoline futures and sell Heating Oil futures.  This is the simplest way to establish the spread, eschewing futures options and ETF options – the options are just too illiquid in the February contracts, which is what we use for this spread.

“Modified Bollinger Band” Sell Signal (Preview)

By Lawrence G. McMillan

A few of our subscribers have been rather nervous about the fact that the mBB sell signal has not produced immediate results.  The sell signal occurred on October 25th, with $SPX roughly at 2557.  Even though $SPX has rallied about 1% since then, it has not come close to stopping us out – an action which would require $SPX closing above the +4σ Band.  Since that Band has raced away to the upside, we have a trade that is sort of in suspended animation if you will.   We bought puts to enter the trade, so one knows exactly what his maximum dollar loss could be.  However, we are still of the opinion that this market is tiring out and the sell signal still has a good chance to work.

Weekly Stock Market Commentary 11/10/17

By Lawrence G. McMillan

Yesterday's action was the first time in quite a while that the market has reacted to negative news. An overbought $SPX sold off nearly 30 points on news that the Senate is going to delay a corporate tax cut bill until 2019. But then the bulls came to the rescue once again, regaining about two-thirds of the losses in a positive intraday reversal. Not only does that still prove that the $SPX chart is positive, but it also establishes a support area at roughly 2565 -- the place where both last week and this week intraday selling halted, and a strong intraday upward reversal began.

Weekly Stock Market Commentary 11/3/2017

By Lawrence G. McMillan

Stock prices continue to rise, in general. There does seem to be a slowing of the upward momentum, but considering how overbought the market had gotten, much more was expected of the bears.

The $SPX chart remains bullish, in that it is rising, and all of its trend lines are rising as well. The index has still not closed below its rising 20-day moving average since early September -- a period of nearly two months.

Weekly Stock Market Commentary 10/27/17

By Lawrence G. McMillan

The $SPX chart in Figure 1 is still a bullish chart. The moving averages are all trending higher. There is support at 2544 (this week's intraday reversal low), with more important support at 2510 and 2480. A close below 2510 would be somewhat bearish, and a close below 2480 would change the chart to an outright bearish one, in my opinion. But at current levels, there is room for a modest correction without completely rolling over into a bear market.

The weighted equity-only put-call ratio has just rolled over to a sell signal, according to the computer programs that we use to analyze these charts. The standard ratio (Figure 2) has not yet been declared a "sell."

Weekly Stock Market Commentary 10/20/17

By Lawrence G. McMillan

The S&P 500 Index ($SPX) has now made a new all-time closing or intraday high on 15 of the last 17 trading days. When the bears fail to capitalize on a selling opportunity such as Thursday, the bulls come back with a vengeance. The $SPX chart remains positive, with support at 2510.

Equity-only put-call ratios have turned bullish once again. Both of these ratios have begun to decline again, and when put-call ratios are declining, that is bullish for stocks.

Breadth is probably the weakest area right now, as it has been waning for several days now. Even so, the breadth oscillators are (barely) clinging to buy signals right now.

Weekly Stock Market Commentary 10/13/2017

By Lawrence G. McMillan

The major indices pushed to new all-time highs again this week, although at a snail's pace.  The $SPX chart is in a strong uptrend, and that is simply bullish.  In the traditional sense, there is support at 2510, 2480, and 2400.

The equity-only put-call ratios have both rolled over to sell signals. These sell signals are confirmed by the computer programs that we use to analyze these charts, as well as by the naked eye (well, sort of).

Market breadth has been generally positive -- enough so that the breadth oscillators remain on buy signals.  Meanwhile, the cumulative advance-decline lines have made new all-time highs as well.

Weekly Stock Market Commentary 10/6/2017

By Lawrence G. McMillan

The strength of the market was on full display this week. The indicators are still in bullish agreement with this move, but there are a couple of potential overbought sell signals setting up.

One overbought condition is that $SPX is above the "modified Bollinger Bands" shown in Figure 1. There is support at 2510, 2480, and 2400.

The weighted equity-only put-call ratio remains on a strong buy signal (Figure 3). It is now approaching the lower regions of its chart, so it can be classified as mildly overbought, but it has not reached the June (multi-year) lows yet. The standard ratio is not as bullish, as it has been moving sideways for nearly two weeks.

Weekly Stock Market Commentary 9/29/17

By Lawrence G. McMillan

Finally, there has been some follow-through movement to the upside. $SPX has made new all-time closing and intraday highs on the last two days. This keeps the $SPX chart bullish, of course. There is still the strong support at 2480 (the level from which the last major breakout occurred), and now there is also support at 2488 -- last week's lows.

The equity-only put-call ratios have slowly been working their way lower on the charts. That means they are still on buy signals. Call buying has remained fairly strong over the past two weeks, even though $SPX has been moving sideways.

This is Why One Uses Trailing Stops

By Lawrence G. McMillan

Intercept Pharm (ICPT) was crushed on Thursday, falling 24 points after the FDA issued a warning on an ICPT liver drug. The stock had previously been in a negative technical pattern, having recently broken down below multiple support at 104. It had tried to rally back, but couldn’t overcome resistance. Stock volume patterns are terrible. There is resistance at 86-90.

Trading or investing whether on margin or otherwise carries a high level of risk, and may not be suitable for all persons. Leverage can work against you as well as for you. Before deciding to trade or invest you should carefully consider your investment objectives, level of experience, and ability to tolerate risk. The possibility exists that you could sustain a loss of some or all of your initial investment or even more than your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading and investing, and seek advice from an independent financial advisor if you have any doubts. Past performance is not necessarily indicative of future results.
Visit the Disclosure & Policies page for full website disclosures.